How's the Capital Raise Going to Work?, page-42

Hmmm, @Steini and @dalts66 either of you honorable enough to admit I was right?

I explained why the L1 facility was not going to work

And now CHM has to rely on Hopper's "sophisticated" mates only this time they're coming off:

(a) a string of under-water capital raises across his biotech businesses; and

(b) CHM's management all but confirming no chance of positive trial progress reporting before year's-end at best (so limited chance to dump on market for a short term profit).

I'll be seriously impressed if the cap-raise gets away above 4c, and more impressed if the SP doesn't drop below 2c prior to year-end. Almost getting to an existential threat with this one ...

(and FYI dalts66, the 4c is not an "audited report", its just filled out internally).